LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer and the MindBody GLP-1 System. The findings reveal that when used ...

LifeVantage Corporation ( NASDAQ: LFVN) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Reed Anderson – Managing Director-ICR Steve Fife – President and Chief Executive Officer Carl Aure ...

Moreover, LifeVantage released a study showing the combined use of two of its products, Protandim® Nrf2 Synergizer® and MindBody GLP-1 System™, activates additional genes linked to organ health.

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...

including its Protandim® product line, LifeVantage® Omega+ and ProBio dietary supplements, the TrueScience® line of Nrf2 infused skin care and hair care products, Petandim® for Dogs ...

Good day, ladies and gentlemen and thank you for standing by. Welcome to today's conference call to discuss LifeVantage's second quarter of fiscal 2025 results. (Operator Instructions) Hosting ...

Good day, ladies and gentlemen and thank you for standing by. Welcome to today's conference call to discuss LifeVantage's second quarter of fiscal 2025 results. (Operator Instructions) Hosting today's ...

Nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant pathway is an important endogenous antioxidant pathway, which plays crucial roles in maintaining human health as its protection against ...